1187929-33-4 Usage
Uses
Used in Pharmaceutical Industry:
(R)-4-Boc-3-aminomethylmorpholine is used as a synthetic intermediate for the development of new pharmaceuticals. Its ability to form complex molecules makes it valuable in the synthesis of drug candidates with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, (R)-4-Boc-3-aminomethylmorpholine serves as a key component in the creation of novel agrochemicals. It contributes to the development of pesticides, herbicides, and other crop protection agents, enhancing agricultural productivity and crop safety.
Used in Specialty Chemicals Production:
(R)-4-Boc-3-aminomethylmorpholine is utilized as a building block in the production of specialty chemicals. Its versatility in organic synthesis allows for the creation of unique chemical entities for specific industrial applications, such as in materials science, coatings, and adhesives.
Each of these applications takes advantage of (R)-4-Boc-3-aminomethylmorpholine's unique chemical properties, particularly its reactivity and the protective role of the Boc group, to advance the development of new and improved products across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1187929-33-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,7,9,2 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1187929-33:
(9*1)+(8*1)+(7*8)+(6*7)+(5*9)+(4*2)+(3*9)+(2*3)+(1*3)=204
204 % 10 = 4
So 1187929-33-4 is a valid CAS Registry Number.
InChI:InChI=1S/C10H20N2O3/c1-10(2,3)15-9(13)12-4-5-14-7-8(12)6-11/h8H,4-7,11H2,1-3H3/t8-/m1/s1
1187929-33-4Relevant academic research and scientific papers
NOVEL PYRAZOLO-PYRROLO-PYRIMIDINE-DIONE DERIVATIVES AS P2X3 INHIBITORS
-
, (2019/05/15)
The present invention covers substituted Pyrazolo-pyrrolo-pyrimidine-dione (PPPD) compounds of general formula (I): in which R1, R2 and R3 are as defined herein, methods of preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of neurogenic diseases, as a sole agent or in combination with other active ingredients.
